-
1
المؤلفون: Chunyan Lan, Zhimin Liu, Dongqin Zhu, Fan Yang, Minjun He, Hongyu Peng, Chongjie Tong, Xiao-Long Zhang, Xin Huang, Jiani C. Yin, Junli Zhang, Yang Shao
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Time Factors, Pyridines, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Phases of clinical research, Uterine Cervical Neoplasms, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Immunotherapy Biomarkers, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Apatinib, Immune Checkpoint Inhibitors, RC254-282, Cervical cancer, biology, medicine.diagnostic_test, High-Throughput Nucleotide Sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, drug therapy, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, Signal Transduction, Adult, medicine.medical_specialty, Combination therapy, Immunology, Antibodies, Monoclonal, Humanized, Risk Assessment, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, Biopsy, medicine, PTEN, Humans, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Aged, combination, Pharmacology, business.industry, Gene Expression Profiling, Immunotherapy, medicine.disease, 030104 developmental biology, chemistry, genetic markers, biology.protein, business, Transcriptome
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04b4bdd5597fc08e7efbeb45dcf1695Test
https://jitc.bmj.com/content/9/5/e002223.fullTest -
2
المؤلفون: Jeffrey R. Infante, Patrick Schöffski, Michael S. Gordon, Alain Ravaud, Manish Agrawal, John Allan Ellerton, Juliane Manitz, Manish R. Patel, Mary Ruisi, Andrea B. Apolo, Matthew H. Taylor, Luc Dirix, Ding Wang, Keun Wook Lee, Raid Aljumaily, Gregory Pennock, Theodore Gourdin, J.L. Gulley
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Immunology, Antibodies, Monoclonal, Humanized, Gastroenterology, B7-H1 Antigen, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Programmed cell death 1, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, Humans, Until Disease Progression, Solid tumor, RC254-282, Urothelial carcinoma, Aged, Platinum, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Second-line therapy, Carcinoma, Transitional Cell, biology, clinical trials as topic, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Molecular Medicine, Female, business, urinary bladder neoplasms, medicine.drug
وصف الملف: Print
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b9fa96546aac04d870e76ec58182cTest
https://jitc.bmj.com/content/8/2/e001246.fullTest -
3
المؤلفون: Yaping Wu, Brendan D. Curti, Zhaoyu Sun, William L. Redmond, Brady Bernard, Christopher B. Fountain, Peter G. Traber, Takashi Shimada, Yoshinobu Koguchi, Rom Leidner, Eliezer Zomer, Elizabeth Sturgill, George Morris, Venkatesh Rajamanickam, Noriko Iwamoto, Annah S Rolig, Ian Hilgart-Martiszus, J. Rex Horton, Shu Ching Chang, Harold Shlevin
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Immune Checkpoint Inhibitors, T-lymphocytes, RC254-282, Clinical/Translational Cancer Immunotherapy, clinical trials as topic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Blood Proteins, Middle Aged, Treatment Outcome, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, immunohistochemistry, Molecular Medicine, Pectins, Female, Multiple Myeloma, Adult, medicine.medical_specialty, Galectins, Immunology, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Memory T Cells, Immune system, Internal medicine, medicine, Humans, Aged, Pharmacology, Autoimmune disease, business.industry, Squamous Cell Carcinoma of Head and Neck, Myeloid-Derived Suppressor Cells, Immunotherapy, medicine.disease, Head and neck squamous-cell carcinoma, Blockade, 030104 developmental biology, Myeloid-derived Suppressor Cell, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1c844347afeb00988b18adab8210aeTest
https://jitc.bmj.com/content/9/4/e002371.fullTest -
4
المؤلفون: Elad Sharon, Alexandre Buckley de Meritens, Carol Aghajanian, Susan C. Modesitt, Siqing Fu, Bradley R. Corr, Alexia Iasonos, Alexandra Snyder Charen, Dmitriy Zamarin, Michael A. Carducci, Panagiotis A. Konstantinopoulos, Travis J. Hollmann, Qin Zhou, Claire F. Friedman, Jason A. Konner
المصدر: Journal for Immunotherapy of Cancer
مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Immunology, Population, Phases of clinical research, Uterine Cervical Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Immunology and Allergy, Humans, education, Pharmacology, Cervical cancer, Clinical/Translational Cancer Immunotherapy, combination, education.field_of_study, Chemotherapy, business.industry, Middle Aged, medicine.disease, drug therapy, 030104 developmental biology, female, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, tumor biomarkers, genital neoplasms, Molecular Medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8224f731a5ceb298b098c2d77cf649Test
https://pubmed.ncbi.nlm.nih.gov/33004542Test -
5
المؤلفون: Kazuhiro Usui, Osamu Hataji, Daichi Fujimoto, Toshiyuki Kozuki, Ryoji Kato, Noriyuki Ebi, Sho Saeki, Tomohiro Ozaki, Junichi Shimizu, Yasutaka Chiba, Shunsuke Teraoka, Keiichi Ota, Kazuhiko Nakagawa, Motoyasu Okuno, Kentaro Tanaka, Atsushi Nakamura, Kazumi Nishino, Eriko Miyawaki, Nobuyuki Yamamoto, Yuki Akazawa, Ryo Toyozawa, Hidetoshi Hayashi
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Docetaxel, Kaplan-Meier Estimate, chemotherapy, non–small cell lung cancer, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, 030212 general & internal medicine, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Drug Synergism, Middle Aged, Progression-Free Survival, Drug Combinations, Pemetrexed, 030220 oncology & carcinogenesis, Cohort, Molecular Medicine, Female, PD-1 inhibitors, Cohort study, medicine.drug, Adult, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, Ramucirumab, 03 medical and health sciences, Internal medicine, medicine, Humans, Propensity Score, Lung cancer, Aged, Retrospective Studies, Tegafur, Pharmacology, Chemotherapy, business.industry, medicine.disease, Oxonic Acid, Propensity score matching, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba83574bb219c567e6e85aee8eba114Test
https://jitc.bmj.com/content/8Test/1 /e000350.full -
6
المؤلفون: Alexander Menzies, Prachi Bhave, Alison Weppler, Lauren Julia Brown, Georgina V. Long, Douglas B. Johnson, Clara Allayous, Shahneen Sandhu, Andrew Haydon, Patrick A. Ott, J. Randall Patrinely, Matteo S. Carlino, Céleste Lebbé
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)مصطلحات موضوعية: Male, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Autoimmunity, Pembrolizumab, Inflammatory bowel disease, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, 030212 general & internal medicine, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunosuppression, Middle Aged, Progression-Free Survival, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Immunosuppressive Agents, medicine.drug, CTLA-4 antigen, Adult, medicine.medical_specialty, Combination therapy, Immunology, Ipilimumab, Antibodies, Monoclonal, Humanized, Autoimmune Diseases, Young Adult, 03 medical and health sciences, Internal medicine, melanoma, Humans, Progression-free survival, Aged, Retrospective Studies, Pharmacology, Autoimmune disease, business.industry, medicine.disease, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2d951c799ac374f6affd11324d9fbbTest
https://doi.org/10.1136/jitc-2020-002121Test -
7
المؤلفون: Guoping Ding, Neng Lou, Liping Cao, Xu Sun, Tao Shen, Qiang Yan, Xiaodong Xu, Guoliang Cao, Lifeng Huang, Mingjie Zhang, Qiang Wei, Huilian Huang
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Kaplan-Meier Estimate, Receptors, Interleukin-8B, Metastasis, 0302 clinical medicine, Cancer immunotherapy, Cell Movement, Antineoplastic Combined Chemotherapy Protocols, Tumor-Associated Macrophages, Tumor Microenvironment, Immunology and Allergy, Interferon gamma, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, CD68, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, pancreatic cancer (PC), Drug Synergism, Immunosuppression, Middle Aged, Recombinant Proteins, macrophages, Gene Expression Regulation, Neoplastic, Cytokine, Oncology, 030220 oncology & carcinogenesis, CXCL8, Molecular Medicine, Female, Signal Transduction, medicine.drug, Adult, musculoskeletal diseases, programmed death 1 (PD1), Immunology, Antigens, Differentiation, Myelomonocytic, interferon-gamma (IFN-γ), Interferon-gamma, 03 medical and health sciences, Pancreatectomy, Antigens, CD, Cell Line, Tumor, Pancreatic cancer, medicine, Humans, Interleukin 8, Pancreas, Aged, Pharmacology, CXCR2, cancer immunotherapy, business.industry, Interleukin-8, medicine.disease, Xenograft Model Antitumor Assays, Pancreatic Neoplasms, 030104 developmental biology, Cancer research, Tumor Escape, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9add92f080e2c426b2a829a02b123dfTest
https://doi.org/10.1136/jitc-2019-000308Test -
8
المؤلفون: Yaxiong Zhang, Huaqiang Zhou, Li Zhang
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-4 (2018)مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Anti-PD-L1, B7-H1 Antigen, Carboplatin, Squamous, 0302 clinical medicine, Antineoplastic Agents, Immunological, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, Atezolizumab, Aged, 80 and over, Hazard ratio, Antibodies, Monoclonal, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Anti-PD-1, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, Adult, medicine.medical_specialty, Paclitaxel, Immunology, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, 03 medical and health sciences, Young Adult, Internal medicine, Humans, Lung cancer, Adverse effect, Aged, Pharmacology, Chemotherapy, business.industry, medicine.disease, Confidence interval, 030104 developmental biology, Commentary, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2adfcb3d2075f280dbefe576a78b0a22Test
http://europepmc.org/articles/PMC6276157Test -
9
المؤلفون: Fengxi Su, Herui Yao, Liang Jin, Wan Yee Lau, Shicheng Su, Ying Li, Erwei Song, Ying Wang, Qian Li, Quanren Wang, Qiang Liu, Zefei Jiang, Jieqiong Liu
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Pyridines, Programmed Cell Death 1 Receptor, Administration, Oral, Angiogenesis Inhibitors, Triple Negative Breast Neoplasms, clinical trials, phase II as topic, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, breast neoplasms, Tumor Microenvironment, Clinical endpoint, Immunology and Allergy, Medicine, Apatinib, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Drug Synergism, Middle Aged, Progression-Free Survival, 030220 oncology & carcinogenesis, Cohort, Molecular Medicine, Administration, Intravenous, Female, immunotherapy, Adult, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, Breast cancer, Internal medicine, Humans, Dosing, Adverse effect, Response Evaluation Criteria in Solid Tumors, Pharmacology, business.industry, medicine.disease, Regimen, 030104 developmental biology, chemistry, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8db20b6267999ff0db12cb7c5c79c03Test
https://doi.org/10.1136/jitc-2020-000696Test -
10
المؤلفون: Anirban Maitra, Edwin R. Parra, Niharika B. Mettu, Priti Patel, Michael J. Overman, Sattva S. Neelapu, Pankaj Vats, Charles D. Lopez, Chandan Kumar-Sinha, Al B. Benson, Richard E. Davis, Lianchun Xiao, Lin Tao, Veerendra Munugalavadla, Milind Javle
المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Administration, Oral, Phases of clinical research, Pembrolizumab, clinical trials, phase II as topic, 0302 clinical medicine, Pancreatic tumor, Antineoplastic Combined Chemotherapy Protocols, Agammaglobulinaemia Tyrosine Kinase, Tumor Microenvironment, Immunology and Allergy, RC254-282, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, 0303 health sciences, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 3. Good health, Pyrazines, 030220 oncology & carcinogenesis, Benzamides, Molecular Medicine, Administration, Intravenous, Female, immunotherapy, Carcinoma, Pancreatic Ductal, Adult, CTLA-4 antigen, medicine.medical_specialty, Combination therapy, Immunology, Antibodies, Monoclonal, Humanized, Proof of Concept Study, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Pancreatic cancer, medicine, Humans, Bruton's tyrosine kinase, Aged, 030304 developmental biology, Pharmacology, business.industry, Myeloid-Derived Suppressor Cells, Immunotherapy, medicine.disease, Pancreatic Neoplasms, Clinical trial, biology.protein, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed66177043a82425ca7f36661138b605Test
https://doi.org/10.1136/jitc-2020-000587Test